Table 1 Baseline characteristics of the 23 patients with severe drug-induced hepatotoxicity
Patients who stopped anti-TB drugs and received hepatoprotective drugs (N = 17) | Patients who stopped anti-TB drugs but did not receive hepatoprotective drugs (N = 6) | P value | |
|---|---|---|---|
Sex | 1.00 | ||
Male | 12 | 4 | |
Female | 5 | 2 | |
Age, years | 64 ± 20 | 58 ± 22 | 0.58 |
Peak AST (IU/dl) | 477 ± 404 | 278 ± 156 | 0.31 |
Peak ALT (IU/dl) | 362 ± 188 | 262 ± 132 | 0.55 |